Enovix (NASDAQ:ENVX) 주식

ENOVIX CORP

Enovix

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

stpckchartbenzingaai2023_stock_market_trading_setup_close_up_of_multipl_8fe49d0f-1b96-4300-8432-bd41086c3559_1

CVNA

ENVX

GRAB

PLTR

TSLA

수요일(19일) 미국 주요 지수는 상승 마감했다 소매 투자자와 트레이더들의 주목을 받은 상위 종목은 다음과 같다. 팔란티어, 카바나, 에노빅스, 그랩 및 테슬라

수요일 주목받은 주식: 팔란티어, 카바나, 에노빅스, 그랩 및 테슬라

Intel, Cleanspark, Super Micro Computer, Upstart, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Equities

News

Markets

FUBO

월요일 주목받은 주식: 메타, 트럼프 미디어, 푸보TV, 이노빅스 및 테슬라

Global

After-Hours Center

Movers

Tech

이노빅스(NASDAQ:ENVX)의 주식은 회사가 말레이시아 Fab2의 현장 수용 테스트를 완료했다고 발표한 후 월요일 시간외 거래에서 약 10% 급등했다. 무슨 일이 있었나: 이노빅스(Enovix)는 지난 12월 말에 Fab2의 고용량 제조 라인에 대한 현장 수용 테스트를 완료했다고 밝혔다. 이 배터리 제조 회사는 올해 말 대량 생산을 시작할 계획이다.

이노빅스 주식이 월요일 시간외 거래에서 약 10% 급등: 무슨 일이?

Enovix Corp

Goldman Sachs analyst Alexander Blostein maintains Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) with a Neutral and raises the price target from $16.25 to $16.75.

Price Target

Analyst Ratings

Goldman Sachs Maintains Neutral on Invesco, Raises Price Target to $16.75

Goldman Sachs analyst Alexander Blostein maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Buy and raises the price target from $994 to $1115.

Goldman Sachs Maintains Buy on BlackRock, Raises Price Target to $1115

Cloud infrastructure provider CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) is in renewed discussions to acquire Bitcoin miner Core Scientific Inc., <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46122921/core-scientific-stock-surges-on-acquisition-reports-with-coreweave">according to reports</a>. Here&#8217;s why the stock <a href="https://www.benzinga.com/quote/CRWV/news">has been volatile</a>.
What To Know: This potential merger has drawn <a href="https://www.benzinga.com/markets/equities/25/06/46137965/crwv-corz-potential-deal-could-unlock-2-8-billion-hidden-value-for-bitcoin-miner-says-morgan-stanley">significant interest</a>, with a Morgan Stanley forecast suggesting the deal could boost Core Scientific's market capitalization by an impressive $2.8 billion.
This new takeover attempt, reported by the Wall Street Journal, could see a deal finalized within weeks. The development comes about a year after Core Scientific, <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46128583/crypto-mining-stocks-surge-thursday-what-happened">now valued</a> at approximately $4.87 billion, rejected a $5.75 per share offer from CoreWeave, which it deemed an undervaluation.
The two companies are already connected through a significant 12-year, $10 billion hosting partnership. Analysis <a href="https://www.benzinga.com/markets/equities/25/06/46137965/crwv-corz-potential-deal-could-unlock-2-8-billion-hidden-value-for-bitcoin-miner-says-morgan-stanley">shared</a> by Eric Jackson of EMJ Capital highlights that Core Scientific reaps a highly favorable 75%-80% profit margin from this existing contract. This suggests potential profits of around $7.75 billion, a figure that eclipses Core Scientific's current market capitalization.
The acquisition talks underscore the intense demand for data center capacity and power, driven by the artificial intelligence sector. CoreWeave, a company valued at roughly $75.87 billion with major clients like Microsoft and Meta, is seeking to expand its infrastructure.
Price Action: CRWV shares are trading higher by 5.24% to $166.49 Friday afternoon. The stock has a 52-week high of $187.00 and a 52-week low of $33.52.
Read Also: <a href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/06/46097418/coreweave-ipo-was-fantastic-entry-point-but-stock-now-a-little-overheated">CoreWeave IPO Was &#8216;Fantastic Entry Point,&#8217; But Stock Now &#8216;A Little Overheated&#8217;</a>
<h2 class="wp-block-heading">How To Buy CRWV Stock</h2>
By now you're likely curious about how to participate in the market for CoreWeave &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of CoreWeave, which is trading at $165.01 as of publishing time, $100 would buy you 0.61 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

CRWV

What's Going On With CoreWeave (CRWV) Stock?

BMO Capital analyst Tamy Chen maintains Alimentation Couche-Tard (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ATD#TSX">ATD</a>) with a Outperform and lowers the price target from C$82 to C$76.

TSX:ATD

BMO Capital Maintains Outperform on Alimentation Couche-Tard, Lowers Price Target to C$76

Goldman Sachs Asset Management is cranking up the volume in fixed income. Thursday, the company debuted two new <a href="https://www.benzinga.com/etfs">actively managed ETFs</a>, the Goldman Sachs Core Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBND#NYSE">GBND</a>) and the Goldman Sachs Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIGL#NYSE">GIGL</a>), as investor interest moves toward more active approaches in a volatile rate landscape.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/06/46143842/t-rowe-price-launches-global-etfs-to-nudge-investors-out-of-their-comfort-zone">T. Rowe Price Launches Global ETFs To Nudge Investors Out Of Their Comfort Zone</a>
<h2 class="wp-block-heading">The Case For Active Fixed Income</h2>
In a backdrop of macroeconomic uncertainty and rate whiplash, advisers are reconsidering their bond allocations. Passive techniques, though cost-effective, can miss the responsiveness that&#8217;s necessary in today&#8217;s bond market. That is where active managers like Goldman Sachs perceive an opportunity.
<h3 class="wp-block-heading">GBND: A Flexible Core Holding</h3>
The Goldman Sachs Core Bond ETF is constructed to be a foundation for diversified portfolios. It provides exposure to investment-grade fixed income asset classes, government bonds, corporates, and securitized debt, through a dual objective of capital appreciation as well as income generation. The ETF has a 0.25% net expense ratio, making it a competitive active peer.
<h3 class="wp-block-heading">GIGL: Focusing On Corporate Credit</h3>
For those looking for more focused corporate bond exposure, the Goldman Sachs Corporate Bond ETF does just that. It is largely invested in investment-grade corporate debt with the room to venture into high-yield when it makes sense. GIGL charges a 0.29% fee, reflecting its active, tactical strategy.
<h2 class="wp-block-heading">Rising Demand for Active Strategies</h2>
This launch comes amid a sea change in investor preferences. According to ETFGI, in May, actively managed fixed-income ETFs pulled in a staggering $82 billion in net inflows, nearly double the $43 billion recorded during the same period in 2024, and a record $17 billion in inflows that month alone. The asset base for active ETFs has grown to approximately $1.39 trillion, marking 62 consecutive months of net inflows.
Why the change? With Fed uncertainty, inflation persistence, and geopolitical noise circulating, investors seek instantaneous flexibility—active managers can adjust credit quality, duration, and sector exposures in real-time. This flexibility enables funds to adjust their exposure by credit quality and duration during periods of heightened volatility.
Giant players are taking notice: Vanguard is reducing bond ETF fees to remain competitive, BlackRock is ramping up active options in Europe and the U.S., and J.P. Morgan has just rolled out a $2 billion high-yield active ETF. Goldman&#8217;s new ETFs are backed by powerful tailwinds.
With GBND and GIGL, Goldman is wagering that additional investors crave experienced eyes on the fixed income terrain, not simply a set-it-and-forget-it index.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/06/46127406/direxions-new-etfs-let-traders-supercharge-bets-on-cisco-and-qualcomm-with-a-catch">Direxion&#8217;s New ETFs Let Traders Supercharge Bets On Cisco And Qualcomm, With A Catch</a></li>
</ul>
Photo: Shutterstock

New ETFs

ETFs

GBND

GIGL

Goldman Just Launched Two New Bond ETFs; Here's Why Investors Should Pay Attention

BMO Capital analyst Kevin O'Halloran maintains Vizsla Silver (TSX:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#TSX">VZLA</a>) with a Outperform and raises the price target from C$4.5 to C$5.

TSX:VZLA

BMO Capital Maintains Outperform on Vizsla Silver, Raises Price Target to C$5

BMO Capital analyst Jack Matten maintains Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) with a Outperform and raises the price target from $43 to $44.

CRBG

BMO Capital Maintains Outperform on Corebridge Financial, Raises Price Target to $44

Risk appetite surged at the end of the trading week, with the S&amp;P 500 breaking above 6,190 and the Nasdaq 100 extending all-time highs, as investors responded to easing trade tensions and geopolitical <a href="https://www.benzinga.com/markets">risks with robust buying.</a>
President Donald Trump said the U.S. is in the process of finalizing multiple trade agreements, suggesting that four to five deals are either completed or close to completion ahead of a key July 9 deadline. Sentiment was further lifted after Commerce Secretary Howard Lutnick confirmed a new U.S.-China trade accord that includes tariff reductions and safeguards for rare earth imports.
<h1 class="wp-block-heading">Dow Eyes 44,000 As Blue Chips Shine</h1>
The Dow Jones Industrial Average climbed steadily near the 44,000 mark, outperforming other major indexes on the back of major gains among blue-chip names.
Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) jumped 18%, marking its best trading day ever, after reporting quarterly earnings that crushed Wall Street expectations. Boeing Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) advanced 4% following a bullish analyst note from RedBurn Atlantic.
NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) extended its leadership role in the AI sector and beyond, pushing past a $3.8 trillion market capitalization and reinforcing its position as the world's most valuable company.
GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) gained 3.5%, reaching its highest level in 17 years. 
Nearly every S&amp;P sector closed in the green except for energy, which lagged sharply as oil prices headed for their worst weekly drop since March 2023. The easing of military tensions in the Middle East helped pull crude lower, capping a volatile stretch for commodities.
Gold also saw selling pressure, dropping 1.6% to $3,270 per ounce, as traders rotated into risk assets and shrugged off traditional safe havens.
The U.S. dollar extended its losing streak to a seventh straight session, dragging the U.S. Dollar Index to its lowest level since February 2022 — just before the Russian invasion of Ukraine. The dollar is now on track for its worst first half of a year since 1991, weighed down by dovish Fed expectations and U.S. fiscal uncertainties.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg.</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,979.04</td>
<td>1.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,190.09</td>
<td>0.8%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,188.84</td>
<td>0.8%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>22,582.46</td>
<td>0.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) rose 0.7% to $567.88.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 1.2% to $439.25.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;inched 0.5% higher to $548.91.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.7% to $216.94.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 1.4%; the&nbsp;Energy&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.8%.</li>
</ul>
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/06/46146713/trump-dollar-outlook-tariffs-debt">Trump Presidency Ushers In Dollar&#8217;s Worst Six-Month Slide In 34 Years </a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Regulations

Broad U.S. Equity ETFs

Econ #s

Trading Ideas

$BTC

SPDR Dow Jones Industrial Average ETF Trust

NVDA

Select Sector SPDR-Consumer Discretionary

Wall Street Hits Record Highs, Nike Jumps 18%: What's Moving Markets Friday?

BMO Capital analyst Kostas Biliouris downgrades Verve Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) from Outperform to Market Perform and lowers the price target from $20 to $13.5.

Downgrades

VERV

BMO Capital Downgrades Verve Therapeutics to Market Perform, Lowers Price Target to $13.5

Shares of Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) rallied during Friday&#8217;s trading session after the company reported <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46143305/nike-stock-is-climbing-higher-friday-whats-going-on">upbeat fiscal fourth-quarter results on Thursday</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
BofA Securities On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59947083803ad3000162314b/lorraine-hutchinson">Analyst Lorraine Hutchinson</a> reiterated a Buy rating, while raising the price target from $80 to $84.
Nike's sales are poised to improve, and the company could return to growth in the back half of the year, Hutchinson said in a note. Management indicated that Nike witnessed the "worst sales and margin pressure from its turnaround strategy" in the fourth quarter, she added.
The company guided to a gross margin contraction in the fiscal first quarter, which reflects "tariff headwind, ongoing DTC clearance and product and channel mix headwinds," the analyst wrote. Gross margins could improve in the second quarter and there is "upside to our estimates as Nike laps significant promos in both DTC and wholesale with new innovation," she further stated.
Goldman Sachs On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60eef53155f722000105d101/brooke-roach">Analyst Brooke Roach</a> maintained a Buy rating, while lifting the price target from $72 to $81.
Nike reported an earnings beat for the latest quarter and provided "better-than-feared forward commentary against a backdrop of low investor expectations," Roach said.
The company continues to face strong earnings pressure and its recovery could take time, especially in China, the analyst stated. She added, however, that management believes that the worst is over and indicated "several greenshoots within its performance portfolio."
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Needham On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee56ee7bf6000154d12e/tom-nikic">Analyst Tom Nikic</a> reaffirmed a Buy rating, while raising the price target from $56 to $78.
Nike's fourth-quarter results were better than feared, and gave hope that the worst was over, Nikic said. The company is now re-focusing on performance products to drive improvement, he added.
Nike has also recognized the importance of its key wholesale partners, the analyst stated. While margins continue to be under pressure, this is expected to moderate in the back half of the year, he further mentioned.
Telsey Advisory Group On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f9ab74825a7ef0001015b59/cristina-fernandez">Analyst Cristina Fernández</a> reaffirmed a Market Perform rating and price target of $70.
Nike&#8217;s quarterly results had "several encouraging data points," Fernández said. The company reported sales and earnings ahead of expectations, while the gross margin contraction was as anticipated, she added.
The running category, where Nike has innovated the most, grew by high single digits globally, the analyst stated. "Nike noted its wholesale order book is positive for the holiday season, partially due to door expansion," she further wrote.
NKE Price Action: Shares of Nike were up 15.5% to $72.24 at the time of publication on Friday.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in"> Nike Faces $1 Billion Trump Tariff Blow, Plans &#8216;Surgical&#8217; Price Hikes Starting Fall 2025 To Offset Impact</a></li>
</ul>
Photo: Shutterstock

Reiteration

Nike Beats The Street And Says The Worst Is Over

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) with a Market Perform and raises the price target from $50 to $52.

GBCI

Keefe, Bruyette & Woods Maintains Market Perform on Glacier Bancorp, Raises Price Target to $52

WIIM

James Hardie Industries shares are trading higher after William Blair initiated coverage with an Outperform rating.

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/06/2025-06-27_08h54_20.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">More Fuel Coming For Hot AI Trade</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-pce-inflation-hot-ai-trade-spy-mc-06272025">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul class="wp-block-list">
<li>The chart shows SPY has hit a new all time high breaking out above zone 1.&nbsp; Zone 1 was previously resistance and will become support if the breakout is sustained.</li>
<li>Prudent investors will be watching the volume and the velocity of the move today.</li>
<li>RSI on the chart shows that the stock market is slightly overbought and still has room to run.</li>
<li>There is more fuel for the hot AI trade.&nbsp; There is a report that President Trump is planning executive orders to boost AI in the U.S. &nbsp; President Trump previously ordered the production of an AI Action Plan to make "America the world capital in artificial intelligence."&nbsp; The plan is due by July 23, which the White House may declare AI Action Day.</li>
<li>Adding to the extreme bullishness in the stock market is a statement from President Trump on trade deals, "Everybody wants to make a deal and have a part of it… we just signed with China yesterday. We are having some great deals. We have one coming up, maybe with India. A very big one. Where we're going to open up India. In the China deal, we are starting to open up China." 
<ul class="wp-block-list">
<li>The U.S. and China have finalized details of a trade deal framework.&nbsp; China has agreed to loosen rare earth mineral export restrictions in return for the U.S. removing countermeasures.</li>
<li>Indian trade negotiators arrived in the U.S. today to continue talks.</li>
<li>Commerce Secretary Lutnick indicated trade agreements are close with ten major trading partners.</li>
<li>The end of the 90 day pause on reciprocal tariffs is approaching.&nbsp; Adding to bullishness is an expectation in the stock market that it is a soft deadline and negotiations are underway in good faith.</li>
</ul>
</li>
<li>PCE is the Fed&#8217;s favorite inflation gauge.&nbsp; Inflation came slightly hotter than expected.&nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Headline PCE came at 0.1% vs. 0.1% consensus.</li>
<li>Core PCE came at 0.2% vs. 0.1% consensus.</li>
</ul>
</li>
<li>The U.S. economy is 70% consumer based.&nbsp; For this reason, prudent investors pay attention to personal income and personal spending.&nbsp; Personal spending and personal income dropped. &nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Personal spending came at -0.1% vs. 0.2% consensus.</li>
<li>Personal income came at -0.4% vs. 0.4% consensus.</li>
</ul>
</li>
<li>University of Michigan Consumer Sentiment was released at 10am ET.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), and NVIDIA Corp (NVDA).
In the early trade, money flows are neutral in Microsoft Corp (MSFT).
In the early trade, money flows are negative in Tesla Inc TSLA).
In the early trade, money flows are positive in S&amp;P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Market Summary

Opinion

Core PCE Hotter; More Fuel For Hot AI Trade - Trump Says 'A Very Big One' Is Ahead

<h3>Gainers</h3>
<ul>
<li>WF Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFF#NASDAQ">WFF</a>) stock moved upwards by 340.1% to $29.22 during Friday's regular session. The company's market cap stands at $167.2 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) stock moved upwards by 25.16% to $1.89. The company's market cap stands at $47.3 million. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) stock rose 23.32% to $3.12. The market value of their outstanding shares is at $17.4 million. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares increased by 23.29% to $6.4. The company's market cap stands at $198.2 million. </li>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) stock increased by 21.67% to $11.49. The company's market cap stands at $72.5 million. </li>
<li>MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) shares rose 14.6% to $15.27. The company's market cap stands at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock fell 20.9% to $0.14 during Friday's regular session. The market value of their outstanding shares is at $2.6 million. </li>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock declined by 9.01% to $1.01. The market value of their outstanding shares is at $85.1 million. </li>
<li>Voyager Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYG#NYSE">VOYG</a>) shares decreased by 8.89% to $44.6. The market value of their outstanding shares is at $2.8 billion. </li>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) stock fell 8.39% to $1.19. The market value of their outstanding shares is at $40.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOVR

JVSA

KULR

OMEX

VOYG

YGMZ

10 Industrials Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Sonder Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) shares moved upwards by 23.4% to $1.98 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. </li>
<li>High Roller Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ROLR#AMEX">ROLR</a>) shares moved upwards by 21.85% to $3.29. The market value of their outstanding shares is at $22.7 million. </li>
<li>Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) shares rose 15.61% to $72.31. The company's market cap stands at $92.5 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares moved upwards by 13.42% to $1.44. The company's market cap stands at $38.2 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) stock moved upwards by 12.02% to $0.56. The market value of their outstanding shares is at $4.3 million. </li>
<li>Pitanium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTNM#NASDAQ">PTNM</a>) shares rose 11.07% to $7.72. The company's market cap stands at $158.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Perfect Moment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#AMEX">PMNT</a>) shares declined by 42.0% to $0.25 during Friday's regular session. </li>
<li>Epsium Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSM#NASDAQ">EPSM</a>) shares decreased by 25.9% to $16.2. The company's market cap stands at $293.7 million. </li>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) stock fell 19.14% to $0.93. The market value of their outstanding shares is at $82.2 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) stock declined by 18.0% to $4.01. The market value of their outstanding shares is at $995.4 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares declined by 17.57% to $0.63. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) stock decreased by 17.51% to $0.59. The company's market cap stands at $32.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EPSM

LOBO

LVWR

MULN

NDLS

PMNT

PTNM

ROLR

SOND

TLYS

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) shares rose 46.4% to $5.12 during Friday's regular session. The market value of their outstanding shares is at $250.4 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares increased by 43.97% to $11.36. The company's market cap stands at $22.7 million. </li>
<li>Citius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) shares moved upwards by 30.88% to $1.74. The market value of their outstanding shares is at $14.4 million. </li>
<li>I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) shares increased by 27.72% to $2.58. The company's market cap stands at $163.3 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) stock moved upwards by 27.52% to $1.14. The company's market cap stands at $111.2 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock rose 27.39% to $6.65. The company's market cap stands at $2.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) stock decreased by 44.1% to $0.54 during Friday's regular session. The market value of their outstanding shares is at $4.1 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares fell 39.82% to $9.99. The company's market cap stands at $431.8 million. </li>
<li>Achieve Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>) stock declined by 37.32% to $2.2. The company's market cap stands at $121.7 million. </li>
<li>Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) stock fell 34.54% to $1.27. The company's market cap stands at $3.9 million. The company's, Q4 earnings came out yesterday. </li>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) stock decreased by 29.83% to $9.39. The company's market cap stands at $17.7 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares fell 29.08% to $0.33. The company's market cap stands at $7.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHV

ADIL

AEMD

CTOR

CTXR

EYEN

GCTK

IMAB

LIMN

LYRA

OTRK

12 Health Care Stocks Moving In Friday's Intraday Session

Macro Economic Events

Economics

U.S. Baker Hughes Oil Rig Count -6 To 432; U.S. Baker Hughes NatGas Rig Count -2 To 109; U.S. Baker Hughes Total Rig Count 547 Vs 554 Prior

<h3>Gainers</h3>
<ul>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) stock increased by 250.6% to $8.94 during Friday's regular session. The company's market cap stands at $3.2 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares moved upwards by 66.07% to $3.82. The company's market cap stands at $1.0 million. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock moved upwards by 31.72% to $4.9. The company's market cap stands at $124.8 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares rose 19.73% to $5.4. The market value of their outstanding shares is at $2.7 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock rose 19.66% to $16.27. The market value of their outstanding shares is at $23.8 million. </li>
<li>CXApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXAI#NASDAQ">CXAI</a>) shares moved upwards by 17.98% to $1.07. The company's market cap stands at $18.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares fell 40.8% to $0.33 during Friday's regular session. The company's market cap stands at $59.0 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock fell 18.01% to $2.33. The company's market cap stands at $5.1 million. </li>
<li>3 E Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASK#NASDAQ">MASK</a>) shares fell 15.33% to $2.21. The market value of their outstanding shares is at $29.3 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) stock fell 13.89% to $0.42. The company's market cap stands at $75.7 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock declined by 12.04% to $10.09. The company's market cap stands at $191.3 million. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) shares declined by 10.08% to $2.46. The market value of their outstanding shares is at $277.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASTI

AUUD

BZAI

CXAI

LCFY

MASK

SVRE

WOLF

YAAS

12 Information Technology Stocks Moving In Friday's Intraday Session

WF Holding Shares Halted On Circuit Breaker To The Upside, Stock Now Up 340.1%

Truist Securities analyst Joseph Civello maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Buy and raises the price target from $73 to $85.

Truist Securities Maintains Buy on Nike, Raises Price Target to $85

Press Releases

General

Enovix Completes Site Acceptance Testing (SAT) of Fab2

Enovix Secures Landmark Purchase Order for Silicon Batteries

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enovix Corporation- ENVX

Enovix to Release Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Glancy Prongay & Murray LLP Announces Investigation of Enovix Corporation (ENVX)

Comments

Enovix

뉴스

파트너 / 기고자

벤징가 글로벌